Mrs. Karen Rose Fitzgerald is a Albany, New York based nurse practitioner. Her current practice location is 391 Myrtle Ave., Suite 5, The Vascular Group, Pllc, Albany. Patients can reach her at 518-262-5640 or can fax her at 518-262-9413. Mrs. Karen Rose Fitzgerald is FNP and her NPI number (Unique professional ID assigned by NPPES) is 1639144777. Mrs. Karen Rose Fitzgerald has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Mrs. Karen Rose Fitzgerald speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
Name:
Mrs. Karen Rose Fitzgerald
Specialization:
Nurse Practitioner (NP)
Gender:
Female
Credentials:
FNP
Practice Address:
391 Myrtle Ave., Suite 5, The Vascular Group, Pllc, Albany, New York, 12208-3412
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1639144777
NPI Enumeration Date:
22 Feb, 2006
NPI Last Update On:
21 Jul, 2022
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Mrs. Karen Rose Fitzgerald 391 Myrtle Ave Ste 5, Albany, New York
Zip:
12208-3797
Phone Number:
518-262-5640
Fax Number:
518-262-9413
Patients can reach Mrs. Karen Rose Fitzgerald at 391 Myrtle Ave., Suite 5, The Vascular Group, Pllc, Albany, New York or can call to book an appointment on 518-262-5640.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 September, 2024.